Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus.
Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus.
复制标题
Valnoctamide 增强阶段性抑制:治疗苯二氮卓类难治性癫痫持续状态的潜在目标机制。
DOI:
10.1111/epi.12702
复制
发表时间:
2014
期刊:
影响因子:
5.6
通讯作者:
Dudek,FEdward
中科院分区:
文献类型:
--
作者:
Spampanato,Jay;Dudek,FEdward
Valnoctamide (VCD), a derivative of valproate, suppresses electrographic seizures in animal models of status epilepticus (SE), even when the seizures are resistant to benzodiazepines (BZDs). We therefore tested the effect of VCD on miniature inhibitory postsynaptic currents (mIPSCs) in CA1 pyramidal cells to determine if VCD acts directly on γ‐aminobutyric acid (GABA)Areceptors. Bath‐applied VCD induced a specific, rapid, dose‐dependent, and reversible slowing of the decay of mIPSCs (i.e., increased time constant) with no effect on their frequency or amplitude. This is similar to the effect of BZDs on mIPSCs, but the effect of VCD persisted in the presence of the BZD‐binding site antagonist flumazenil, and was additive to the effect of the BZD, diazepam. These data suggest that VCD acts through a different binding site than that of BZDs, which likely accounts for its effect on BZD‐refractory SE.A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.